July 30, 2015
Charles River remains sole provider of safety assessment and development DMPK
July 17, 2015
Combined company has received a commitment of up to $125 million in minority equity financing
June 24, 2015
Both contracts concern the development of PharmaCyte Biotech’s treatment for insulin-dependent diabetes
Sign up now to receive the free weekly newsletter, and more!